published patent: Protective agent for retinal nerve or optic nerve

TitleProtective agent for retinal nerve or optic nerve
Priority Date2007-01-31 JP20070021852
2008-01-30 PCT/JP2008051338
Inventors
Issue Date2008
Citation
Australia Published Patent Application AU 2008210970. Australia: IP Australia, 2008 How to Cite?
AbstractThe present invention provides a protective agent for retinal nerve or optic nerve which exerts its effect through a different mechanism from that of conventional therapeutic agents and can be taken for long periods. The present invention is the protective agent for retinal nerve or optic nerve which comprises a compound with aldose reductase inhibiting activity such as the compound represented by the following general formula as an active ingredient. A preferable compound thereof is (2S,4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-carboxamide: wherein X represents a halogen atom or a hydrogen atom, R1 and R2 independently represent a hydrogen atom or an optionally substituted C1 to C6 alkyl group, or R 1 and R 2 , together with a nitrogen atom bound thereto, or optionally another nitrogen atom or an oxygen atom, are combined to form a 5- to 6-membered heterocycle.
Persistent Identifierhttp://hdl.handle.net/10722/176547

 

DC FieldValueLanguage
dc.date.accessioned2012-11-30T08:38:06Z-
dc.date.available2012-11-30T08:38:06Z-
dc.date.issued2008-
dc.identifier.citationAustralia Published Patent Application AU 2008210970. Australia: IP Australia, 2008en_HK
dc.identifier.urihttp://hdl.handle.net/10722/176547-
dc.description.abstractThe present invention provides a protective agent for retinal nerve or optic nerve which exerts its effect through a different mechanism from that of conventional therapeutic agents and can be taken for long periods. The present invention is the protective agent for retinal nerve or optic nerve which comprises a compound with aldose reductase inhibiting activity such as the compound represented by the following general formula as an active ingredient. A preferable compound thereof is (2S,4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-carboxamide: wherein X represents a halogen atom or a hydrogen atom, R1 and R2 independently represent a hydrogen atom or an optionally substituted C1 to C6 alkyl group, or R 1 and R 2 , together with a nitrogen atom bound thereto, or optionally another nitrogen atom or an oxygen atom, are combined to form a 5- to 6-membered heterocycle.en_HK
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License For Public Patent Documentsen_US
dc.titleProtective agent for retinal nerve or optic nerveen_HK
dc.typePatenten_US
dc.description.naturepublished_or_final_versionen_US
dc.contributor.inventorChung, SKen_HK
dc.contributor.inventorHibi, Chihiroen_HK
dc.contributor.inventorChung, Stephenen_HK
patents.identifier.applicationAU 20080210970en_HK
patents.description.assigneeSANWA KAGAKU KENKYUSHO COen_HK
patents.description.countryAustraliaen_HK
patents.date.publication2008-08-07en_HK
patents.date.application2008-01-30en_HK
patents.date.priority2007-01-31 JP20070021852en_HK
patents.date.priority2008-01-30 PCT/JP2008051338en_HK
patents.description.ccAUen_HK
patents.identifier.publicationAU 2008210970en_HK
patents.relation.familyAU 2008210970 (A1) 2008-08-07en_HK
patents.relation.familyCA 2673751 (A1) 2008-08-07en_HK
patents.relation.familyCN 101594884 (A) 2009-12-02en_HK
patents.relation.familyEP 2110141 (A1) 2009-10-21en_HK
patents.relation.familyUS 2010216856 (A1) 2010-08-26en_HK
patents.relation.familyWO 2008093691 (A1) 2008-08-07en_HK
patents.description.kindA1en_HK
patents.typePatent_publisheden_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats